| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.02e-10 | 188 | 40 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | integrin binding | 2.51e-05 | 175 | 40 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 2.52e-05 | 616 | 40 | 8 | GO:0030545 | |
| GeneOntologyMolecularFunction | structural molecule activity | 5.28e-05 | 891 | 40 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 9.47e-05 | 547 | 40 | 7 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.03e-04 | 554 | 40 | 7 | GO:0030546 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.66e-04 | 599 | 40 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.55e-04 | 12 | 40 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 3.51e-04 | 14 | 40 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | Notch binding | 1.33e-03 | 27 | 40 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | hormone activity | 2.49e-03 | 135 | 40 | 3 | GO:0005179 | |
| GeneOntologyMolecularFunction | frizzled binding | 3.20e-03 | 42 | 40 | 2 | GO:0005109 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.53e-03 | 749 | 40 | 6 | GO:0005509 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ADAMTS16 MST1 LAMA3 LRP4 WNT10A LAMB1 NTN1 LTBP3 FBN2 TNC SLC40A1 ADAM15 WNT16 MIB1 | 3.65e-08 | 1269 | 39 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of cell migration | PCSK5 MST1 LAMA3 LAMB1 NTN1 RELN FBN2 SEMA5B TNC TNXB ADAM15 WDR62 | 1.41e-06 | 1211 | 39 | 12 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of cell motility | PCSK5 MST1 LAMA3 LAMB1 NTN1 RELN FBN2 SEMA5B TNC TNXB ADAM15 WDR62 | 2.53e-06 | 1280 | 39 | 12 | GO:2000145 |
| GeneOntologyBiologicalProcess | regulation of locomotion | PCSK5 MST1 LAMA3 LAMB1 NTN1 RELN FBN2 SEMA5B TNC TNXB ADAM15 WDR62 | 3.67e-06 | 1327 | 39 | 12 | GO:0040012 |
| GeneOntologyBiologicalProcess | neuron development | TENM1 BOC LAMA3 LRP4 LAMB1 NTN1 RELN TENM4 SEMA5B TNC TNXB GPRIN2 | 1.00e-05 | 1463 | 39 | 12 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon guidance | 1.47e-05 | 285 | 39 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.50e-05 | 286 | 39 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 2.09e-05 | 4 | 39 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | axon development | 2.21e-05 | 642 | 39 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | embryo implantation | 3.33e-05 | 97 | 39 | 4 | GO:0007566 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 3.76e-05 | 1141 | 39 | 10 | GO:0045597 | |
| GeneOntologyBiologicalProcess | axonogenesis | 8.10e-05 | 566 | 39 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 9.68e-05 | 8 | 39 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | neuron projection development | 1.02e-04 | 1285 | 39 | 10 | GO:0031175 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.41e-04 | 619 | 39 | 7 | GO:0002009 | |
| GeneOntologyBiologicalProcess | odontogenesis | 1.86e-04 | 151 | 39 | 4 | GO:0042476 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.90e-04 | 11 | 39 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 2.27e-04 | 296 | 39 | 5 | GO:0048762 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 2.68e-04 | 13 | 39 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 2.68e-04 | 13 | 39 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 3.02e-04 | 1190 | 39 | 9 | GO:0008284 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.12e-04 | 14 | 39 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | motor neuron migration | 3.60e-04 | 15 | 39 | 2 | GO:0097475 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 4.48e-04 | 748 | 39 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 4.55e-04 | 750 | 39 | 7 | GO:0048729 | |
| GeneOntologyBiologicalProcess | glial cell migration | 4.64e-04 | 80 | 39 | 3 | GO:0008347 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 6.46e-04 | 372 | 39 | 5 | GO:0060485 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 6.78e-04 | 802 | 39 | 7 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 7.68e-04 | 819 | 39 | 7 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 7.79e-04 | 1077 | 39 | 8 | GO:0098609 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 8.07e-04 | 826 | 39 | 7 | GO:0048858 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 8.60e-04 | 23 | 39 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 9.35e-04 | 611 | 39 | 6 | GO:0045859 | |
| GeneOntologyBiologicalProcess | tube development | 9.95e-04 | 1402 | 39 | 9 | GO:0035295 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.00e-03 | 410 | 39 | 5 | GO:0031589 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 1.02e-03 | 25 | 39 | 2 | GO:2001224 | |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 1.08e-03 | 107 | 39 | 3 | GO:0042475 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.12e-03 | 421 | 39 | 5 | GO:0060562 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.13e-03 | 875 | 39 | 7 | GO:0045596 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.22e-03 | 249 | 39 | 4 | GO:0007565 | |
| GeneOntologyBiologicalProcess | epithelium development | 1.38e-03 | 1469 | 39 | 9 | GO:0060429 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.43e-03 | 911 | 39 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | cerebral cortex radial glia-guided migration | 1.47e-03 | 30 | 39 | 2 | GO:0021801 | |
| GeneOntologyBiologicalProcess | telencephalon glial cell migration | 1.47e-03 | 30 | 39 | 2 | GO:0022030 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.58e-03 | 927 | 39 | 7 | GO:0030155 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.65e-03 | 270 | 39 | 4 | GO:0007160 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.65e-03 | 124 | 39 | 3 | GO:0007229 | |
| GeneOntologyBiologicalProcess | trabecula formation | 1.67e-03 | 32 | 39 | 2 | GO:0060343 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 1.69e-03 | 686 | 39 | 6 | GO:0043549 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 1.72e-03 | 273 | 39 | 4 | GO:0030323 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.06e-03 | 713 | 39 | 6 | GO:0048598 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 2.14e-03 | 290 | 39 | 4 | GO:0044703 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 2.24e-03 | 725 | 39 | 6 | GO:2000147 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 2.25e-03 | 294 | 39 | 4 | GO:0044706 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS16 MST1 LAMA3 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 TNC TNXB FBN3 | 1.40e-10 | 656 | 40 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS16 MST1 LAMA3 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 TNC TNXB FBN3 | 1.46e-10 | 658 | 40 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.32e-08 | 530 | 40 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | microfibril | 1.83e-06 | 13 | 40 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 3.48e-06 | 122 | 40 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.33e-06 | 17 | 40 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | tenascin complex | 2.14e-05 | 4 | 40 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | laminin complex | 1.59e-04 | 10 | 40 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.96e-04 | 59 | 40 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.64e-03 | 332 | 40 | 4 | GO:0005788 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 1.62e-05 | 2 | 21 | 2 | HP:0005900 | |
| HumanPheno | Abnormal upper to lower segment ratio | 4.84e-05 | 3 | 21 | 2 | HP:0012772 | |
| MousePheno | abnormal tooth hard tissue morphology | 4.63e-07 | 63 | 35 | 5 | MP:0003930 | |
| MousePheno | abnormal enamel morphology | 4.56e-06 | 45 | 35 | 4 | MP:0002576 | |
| MousePheno | abnormal craniofacial development | 7.35e-05 | 425 | 35 | 7 | MP:0003935 | |
| MousePheno | abnormal bone structure | ADAMTS16 PCSK5 LRP4 WNT10A LTBP3 FBN1 FBN2 TENM4 TNXB SLC40A1 DKK2 WNT16 | 7.80e-05 | 1379 | 35 | 12 | MP:0003795 |
| MousePheno | syndactyly | 8.21e-05 | 93 | 35 | 4 | MP:0000564 | |
| MousePheno | abnormal tooth development | 1.47e-04 | 108 | 35 | 4 | MP:0000116 | |
| MousePheno | abnormal nail morphology | 1.66e-04 | 43 | 35 | 3 | MP:0000579 | |
| MousePheno | abnormal molar morphology | 2.76e-04 | 51 | 35 | 3 | MP:0002689 | |
| MousePheno | abnormal jaw morphology | 2.89e-04 | 530 | 35 | 7 | MP:0000454 | |
| MousePheno | abnormal posture | 3.23e-04 | 243 | 35 | 5 | MP:0001504 | |
| MousePheno | abnormal craniofacial morphology | PCSK5 LAMA3 LRP4 WNT10A NTN1 LTBP3 FBN1 FBN2 CRIM1 VWDE MIB1 | 3.53e-04 | 1372 | 35 | 11 | MP:0000428 |
| MousePheno | craniofacial phenotype | PCSK5 LAMA3 LRP4 WNT10A NTN1 LTBP3 FBN1 FBN2 CRIM1 VWDE MIB1 | 3.53e-04 | 1372 | 35 | 11 | MP:0005382 |
| MousePheno | abnormal spinal cord dorsal column morphology | 3.96e-04 | 12 | 35 | 2 | MP:0009677 | |
| Domain | EGF | TENM1 PCSK5 LAMA3 LRP4 LAMB1 SNED1 RELN LTBP3 FBN1 FBN2 TENM4 TNC TNXB VWDE ADAM15 FBN3 MEGF10 | 1.90e-22 | 235 | 40 | 17 | SM00181 |
| Domain | EGF-like_dom | TENM1 PCSK5 LAMA3 LRP4 LAMB1 SNED1 RELN LTBP3 FBN1 FBN2 TENM4 TNC TNXB VWDE ADAM15 FBN3 MEGF10 | 5.17e-22 | 249 | 40 | 17 | IPR000742 |
| Domain | EGF_1 | TENM1 LAMA3 LRP4 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 TENM4 TNC TNXB VWDE ADAM15 FBN3 MEGF10 | 7.80e-22 | 255 | 40 | 17 | PS00022 |
| Domain | EGF-like_CS | TENM1 LAMA3 LRP4 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 TENM4 TNC TNXB VWDE ADAM15 FBN3 MEGF10 | 1.17e-21 | 261 | 40 | 17 | IPR013032 |
| Domain | EGF_2 | TENM1 LAMA3 LRP4 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 TENM4 TNC TNXB VWDE ADAM15 FBN3 MEGF10 | 1.51e-21 | 265 | 40 | 17 | PS01186 |
| Domain | EGF_3 | TENM1 LRP4 SNED1 RELN LTBP3 FBN1 FBN2 TENM4 TNC TNXB VWDE ADAM15 FBN3 MEGF10 | 2.93e-17 | 235 | 40 | 14 | PS50026 |
| Domain | Growth_fac_rcpt_ | 1.81e-14 | 156 | 40 | 11 | IPR009030 | |
| Domain | EGF_extracell | 4.22e-11 | 60 | 40 | 7 | IPR013111 | |
| Domain | EGF_2 | 4.22e-11 | 60 | 40 | 7 | PF07974 | |
| Domain | TB | 6.28e-10 | 7 | 40 | 4 | PF00683 | |
| Domain | - | 1.25e-09 | 8 | 40 | 4 | 3.90.290.10 | |
| Domain | cEGF | 2.21e-09 | 26 | 40 | 5 | IPR026823 | |
| Domain | cEGF | 2.21e-09 | 26 | 40 | 5 | PF12662 | |
| Domain | TB | 2.25e-09 | 9 | 40 | 4 | PS51364 | |
| Domain | TB_dom | 2.25e-09 | 9 | 40 | 4 | IPR017878 | |
| Domain | hEGF | 3.30e-09 | 28 | 40 | 5 | PF12661 | |
| Domain | FBN | 9.10e-09 | 3 | 40 | 3 | IPR011398 | |
| Domain | EGF_Ca-bd_CS | 5.59e-08 | 97 | 40 | 6 | IPR018097 | |
| Domain | EGF_CA | 6.31e-08 | 99 | 40 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.71e-08 | 100 | 40 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.51e-08 | 106 | 40 | 6 | IPR000152 | |
| Domain | EGF_CA | 2.20e-07 | 122 | 40 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.42e-07 | 124 | 40 | 6 | IPR001881 | |
| Domain | Laminin_EGF | 9.00e-07 | 35 | 40 | 4 | PF00053 | |
| Domain | EGF_Lam | 9.00e-07 | 35 | 40 | 4 | SM00180 | |
| Domain | EGF_CA | 1.07e-06 | 86 | 40 | 5 | PF07645 | |
| Domain | Laminin_EGF | 1.26e-06 | 38 | 40 | 4 | IPR002049 | |
| Domain | LAMININ_NTER | 5.00e-06 | 16 | 40 | 3 | PS51117 | |
| Domain | Laminin_N | 5.00e-06 | 16 | 40 | 3 | PF00055 | |
| Domain | Laminin_N | 5.00e-06 | 16 | 40 | 3 | IPR008211 | |
| Domain | LamNT | 5.00e-06 | 16 | 40 | 3 | SM00136 | |
| Domain | EGF | 7.03e-06 | 126 | 40 | 5 | PF00008 | |
| Domain | Tox-GHH_dom | 2.68e-05 | 4 | 40 | 2 | IPR028916 | |
| Domain | TENEURIN_N | 2.68e-05 | 4 | 40 | 2 | PS51361 | |
| Domain | Ten_N | 2.68e-05 | 4 | 40 | 2 | IPR009471 | |
| Domain | Tox-GHH | 2.68e-05 | 4 | 40 | 2 | PF15636 | |
| Domain | Ten_N | 2.68e-05 | 4 | 40 | 2 | PF06484 | |
| Domain | EGF_LAM_2 | 3.55e-05 | 30 | 40 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 3.55e-05 | 30 | 40 | 3 | PS01248 | |
| Domain | YD | 4.45e-05 | 5 | 40 | 2 | IPR006530 | |
| Domain | - | 7.88e-05 | 39 | 40 | 3 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.30e-04 | 46 | 40 | 3 | IPR011042 | |
| Domain | NHL | 3.44e-04 | 13 | 40 | 2 | PS51125 | |
| Domain | fn3 | 3.91e-04 | 162 | 40 | 4 | PF00041 | |
| Domain | PLAC | 4.00e-04 | 14 | 40 | 2 | PF08686 | |
| Domain | FN3 | 6.45e-04 | 185 | 40 | 4 | SM00060 | |
| Domain | Wnt | 7.47e-04 | 19 | 40 | 2 | IPR005817 | |
| Domain | PLAC | 7.47e-04 | 19 | 40 | 2 | IPR010909 | |
| Domain | PLAC | 7.47e-04 | 19 | 40 | 2 | PS50900 | |
| Domain | WNT1 | 7.47e-04 | 19 | 40 | 2 | SM00097 | |
| Domain | Wnt_CS | 7.47e-04 | 19 | 40 | 2 | IPR018161 | |
| Domain | wnt | 7.47e-04 | 19 | 40 | 2 | PF00110 | |
| Domain | WNT1 | 7.47e-04 | 19 | 40 | 2 | PS00246 | |
| Domain | FN3 | 8.46e-04 | 199 | 40 | 4 | PS50853 | |
| Domain | FN3_dom | 1.02e-03 | 209 | 40 | 4 | IPR003961 | |
| Domain | Galactose-bd-like | 1.07e-03 | 94 | 40 | 3 | IPR008979 | |
| Domain | - | 1.20e-03 | 24 | 40 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.20e-03 | 24 | 40 | 2 | IPR014715 | |
| Domain | Ephrin_rec_like | 1.30e-03 | 25 | 40 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.30e-03 | 25 | 40 | 2 | IPR011641 | |
| Domain | Fibrinogen_C | 1.52e-03 | 27 | 40 | 2 | PF00147 | |
| Domain | FBG | 1.75e-03 | 29 | 40 | 2 | SM00186 | |
| Domain | - | 1.87e-03 | 30 | 40 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.87e-03 | 30 | 40 | 2 | IPR014716 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.13e-03 | 32 | 40 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.13e-03 | 32 | 40 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 2.13e-03 | 32 | 40 | 2 | PS00514 | |
| Domain | Peptidase_M12B_N | 3.15e-03 | 39 | 40 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.15e-03 | 39 | 40 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.31e-03 | 40 | 40 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 3.31e-03 | 40 | 40 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.31e-03 | 40 | 40 | 2 | PS50214 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAMTS16 LAMA3 LRP4 LAMB1 LTBP3 FBN1 FBN2 TNC TNXB ADAM15 FBN3 | 1.96e-11 | 300 | 31 | 11 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.77e-08 | 140 | 31 | 7 | M587 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.07e-07 | 76 | 31 | 5 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.00e-06 | 84 | 31 | 5 | M7098 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.20e-06 | 37 | 31 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.44e-06 | 44 | 31 | 4 | M26969 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.25e-05 | 66 | 31 | 4 | M18 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.78e-05 | 258 | 31 | 6 | MM14572 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.14e-05 | 25 | 31 | 3 | M39713 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.57e-05 | 32 | 31 | 3 | MM14854 | |
| Pathway | WP_FOCAL_ADHESION | 5.00e-05 | 187 | 31 | 5 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.72e-05 | 199 | 31 | 5 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 6.72e-05 | 199 | 31 | 5 | M39402 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.34e-05 | 39 | 31 | 3 | MM14601 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.12e-04 | 43 | 31 | 3 | M53 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.20e-04 | 44 | 31 | 3 | MM15878 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.30e-04 | 8 | 31 | 2 | M47850 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.37e-04 | 46 | 31 | 3 | M239 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.54e-04 | 11 | 31 | 2 | M158 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.88e-04 | 59 | 31 | 3 | M27218 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 3.35e-04 | 439 | 31 | 6 | M42563 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 4.01e-04 | 66 | 31 | 3 | MM15925 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 4.69e-04 | 302 | 31 | 5 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 6.65e-04 | 326 | 31 | 5 | MM15917 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 7.82e-04 | 19 | 31 | 2 | M47836 | |
| Pathway | WP_PI3KAKT_SIGNALING | 7.93e-04 | 339 | 31 | 5 | M39736 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 9.62e-04 | 89 | 31 | 3 | M39563 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.27e-03 | 98 | 31 | 3 | M39731 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.36e-03 | 25 | 31 | 2 | MM14940 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 1.36e-03 | 25 | 31 | 2 | M118 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.47e-03 | 26 | 31 | 2 | M27239 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 1.71e-03 | 28 | 31 | 2 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.83e-03 | 29 | 31 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.83e-03 | 29 | 31 | 2 | M47377 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 1.91e-03 | 113 | 31 | 3 | M39669 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.96e-03 | 30 | 31 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.96e-03 | 30 | 31 | 2 | M27216 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.96e-03 | 114 | 31 | 3 | MM14571 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 2.23e-03 | 32 | 31 | 2 | M165 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.37e-03 | 33 | 31 | 2 | M39503 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.49e-03 | 124 | 31 | 3 | M27285 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 2.81e-03 | 36 | 31 | 2 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.97e-03 | 37 | 31 | 2 | M47411 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.13e-03 | 38 | 31 | 2 | MM14874 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-03 | 39 | 31 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-03 | 39 | 31 | 2 | MM15165 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.64e-03 | 41 | 31 | 2 | M27778 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 4.35e-03 | 151 | 31 | 3 | M19428 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 4.37e-03 | 45 | 31 | 2 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 4.56e-03 | 46 | 31 | 2 | M47409 | |
| Pathway | WP_CANCER_PATHWAYS | 4.62e-03 | 507 | 31 | 5 | M48302 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.76e-03 | 47 | 31 | 2 | MM14925 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 4.76e-03 | 47 | 31 | 2 | M646 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 5.34e-03 | 325 | 31 | 4 | M12868 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 6.46e-03 | 55 | 31 | 2 | M17807 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 6.69e-03 | 56 | 31 | 2 | M1053 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 7.41e-03 | 59 | 31 | 2 | M46460 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 7.41e-03 | 59 | 31 | 2 | M39886 | |
| Pathway | WP_WNT_SIGNALING | 7.90e-03 | 61 | 31 | 2 | MM15893 | |
| Pubmed | 1.17e-09 | 175 | 40 | 7 | 28071719 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 5.63e-09 | 4 | 40 | 3 | 25034023 | |
| Pubmed | 1.68e-08 | 146 | 40 | 6 | 27068509 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.20e-08 | 26 | 40 | 4 | 34189436 | |
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 7.86e-08 | 8 | 40 | 3 | 23055981 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 9.64e-08 | 37 | 40 | 4 | 34323105 | |
| Pubmed | 1.46e-07 | 210 | 40 | 6 | 16537572 | ||
| Pubmed | 2.47e-07 | 118 | 40 | 5 | 21078624 | ||
| Pubmed | 3.32e-07 | 50 | 40 | 4 | 23658023 | ||
| Pubmed | 3.42e-07 | 126 | 40 | 5 | 16284245 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.83e-07 | 135 | 40 | 5 | 28675934 | |
| Pubmed | 7.81e-07 | 16 | 40 | 3 | 30579834 | ||
| Pubmed | 8.97e-07 | 153 | 40 | 5 | 25037231 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.14e-06 | 18 | 40 | 3 | 39040056 | |
| Pubmed | 1.26e-06 | 164 | 40 | 5 | 32409323 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12399449 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21851253 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12429739 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.29e-06 | 2 | 40 | 2 | 30044367 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 1.29e-06 | 2 | 40 | 2 | 26494287 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.29e-06 | 2 | 40 | 2 | 21440062 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15131124 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9321695 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 1.29e-06 | 2 | 40 | 2 | 12524050 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.29e-06 | 2 | 40 | 2 | 20404337 | |
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 1.29e-06 | 2 | 40 | 2 | 29625025 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.29e-06 | 2 | 40 | 2 | 8791520 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 8120105 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 8856503 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 1.29e-06 | 2 | 40 | 2 | 8307578 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 1.29e-06 | 2 | 40 | 2 | 10504303 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15221638 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.29e-06 | 2 | 40 | 2 | 7744963 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.29e-06 | 2 | 40 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 1.29e-06 | 2 | 40 | 2 | 24833718 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24265020 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 20529844 | ||
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 1.29e-06 | 2 | 40 | 2 | 12359049 | |
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 1.29e-06 | 2 | 40 | 2 | 25524144 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17202312 | ||
| Pubmed | Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration. | 1.29e-06 | 2 | 40 | 2 | 28662401 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23133647 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30306291 | ||
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 1.29e-06 | 2 | 40 | 2 | 9013311 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 1.29e-06 | 2 | 40 | 2 | 16407178 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 1.29e-06 | 2 | 40 | 2 | 1852206 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15455729 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 10359653 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 7509489 | ||
| Pubmed | The effects of tenascin C knockdown on trabecular meshwork outflow resistance. | 1.29e-06 | 2 | 40 | 2 | 23882691 | |
| Pubmed | 1.38e-06 | 71 | 40 | 4 | 33541421 | ||
| Pubmed | 1.38e-06 | 167 | 40 | 5 | 22159717 | ||
| Pubmed | 1.85e-06 | 21 | 40 | 3 | 19806668 | ||
| Pubmed | 2.14e-06 | 22 | 40 | 3 | 27527664 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.98e-06 | 86 | 40 | 4 | 28327460 | |
| Pubmed | Obstructed migration of Purkinje cells in the developing cerebellum of the reeler mutant mouse. | 3.87e-06 | 3 | 40 | 2 | 7506500 | |
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 3.87e-06 | 3 | 40 | 2 | 7687262 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 10825173 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7530141 | ||
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 3.87e-06 | 3 | 40 | 2 | 7694605 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 30201140 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21700711 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 37209968 | ||
| Pubmed | The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. | 3.87e-06 | 3 | 40 | 2 | 12823230 | |
| Pubmed | Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing. | 3.87e-06 | 3 | 40 | 2 | 32273468 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 20301776 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21276136 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 20855508 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.81e-06 | 97 | 40 | 4 | 27559042 | |
| Pubmed | 5.60e-06 | 30 | 40 | 3 | 19282366 | ||
| Pubmed | 5.60e-06 | 30 | 40 | 3 | 15880404 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 12429738 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 7.73e-06 | 4 | 40 | 2 | 10225957 | |
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 7.73e-06 | 4 | 40 | 2 | 25406291 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 20729550 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 16835936 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 10801807 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 7.73e-06 | 4 | 40 | 2 | 12000766 | |
| Pubmed | 8.99e-06 | 35 | 40 | 3 | 30940800 | ||
| Pubmed | 8.99e-06 | 35 | 40 | 3 | 19185060 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 9.50e-06 | 248 | 40 | 5 | 24006456 | |
| Pubmed | 1.25e-05 | 39 | 40 | 3 | 24586192 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 26601954 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 12590922 | ||
| Pubmed | Expression of Wnts in the developing murine secondary palate. | 1.29e-05 | 5 | 40 | 2 | 19598129 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 17255108 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 34411563 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 1.29e-05 | 5 | 40 | 2 | 23493297 | |
| Pubmed | The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. | 1.29e-05 | 5 | 40 | 2 | 7512972 | |
| Pubmed | 1.81e-05 | 44 | 40 | 3 | 23884445 | ||
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 1.93e-05 | 6 | 40 | 2 | 9506922 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 7873879 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 7512897 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 32929029 | ||
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 2.21e-05 | 47 | 40 | 3 | 28813421 | |
| Pubmed | 2.21e-05 | 47 | 40 | 3 | 18351675 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 2.50e-05 | 49 | 40 | 3 | 19562671 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 15162516 | ||
| Interaction | IGFL3 interactions | 6.41e-09 | 75 | 39 | 6 | int:IGFL3 | |
| Interaction | NTN5 interactions | 1.24e-07 | 24 | 39 | 4 | int:NTN5 | |
| Interaction | ST14 interactions | 1.27e-07 | 207 | 39 | 7 | int:ST14 | |
| Interaction | FBXO6 interactions | 7.06e-06 | 717 | 39 | 9 | int:FBXO6 | |
| Interaction | SLURP1 interactions | 8.22e-06 | 144 | 39 | 5 | int:SLURP1 | |
| Interaction | FBXO2 interactions | 1.22e-05 | 411 | 39 | 7 | int:FBXO2 | |
| Interaction | TENM1 interactions | 2.12e-05 | 28 | 39 | 3 | int:TENM1 | |
| Interaction | MAP10 interactions | 2.36e-05 | 29 | 39 | 3 | int:MAP10 | |
| Interaction | WNT10A interactions | 4.97e-05 | 37 | 39 | 3 | int:WNT10A | |
| Interaction | DYRK1A interactions | 8.00e-05 | 552 | 39 | 7 | int:DYRK1A | |
| Interaction | LYPD4 interactions | 9.21e-05 | 123 | 39 | 4 | int:LYPD4 | |
| Interaction | CACNA1A interactions | 9.21e-05 | 123 | 39 | 4 | int:CACNA1A | |
| Interaction | ZDHHC15 interactions | 9.81e-05 | 125 | 39 | 4 | int:ZDHHC15 | |
| Interaction | MFAP5 interactions | 1.39e-04 | 52 | 39 | 3 | int:MFAP5 | |
| Interaction | ZFP41 interactions | 1.82e-04 | 57 | 39 | 3 | int:ZFP41 | |
| Interaction | TIMP2 interactions | 1.86e-04 | 277 | 39 | 5 | int:TIMP2 | |
| Interaction | LYPD1 interactions | 1.92e-04 | 58 | 39 | 3 | int:LYPD1 | |
| Interaction | PRG2 interactions | 2.12e-04 | 285 | 39 | 5 | int:PRG2 | |
| Interaction | MFAP2 interactions | 2.38e-04 | 12 | 39 | 2 | int:MFAP2 | |
| Interaction | C1orf54 interactions | 2.98e-04 | 167 | 39 | 4 | int:C1orf54 | |
| Interaction | MBD1 interactions | 4.44e-04 | 77 | 39 | 3 | int:MBD1 | |
| Interaction | CST9L interactions | 4.61e-04 | 78 | 39 | 3 | int:CST9L | |
| Interaction | KLKB1 interactions | 4.87e-04 | 17 | 39 | 2 | int:KLKB1 | |
| Cytoband | 5p15 | 1.55e-05 | 7 | 40 | 2 | 5p15 | |
| Cytoband | 7q22 | 5.10e-04 | 38 | 40 | 2 | 7q22 | |
| Cytoband | 10q11.22 | 5.94e-04 | 41 | 40 | 2 | 10q11.22 | |
| Cytoband | 18q11.2 | 7.81e-04 | 47 | 40 | 2 | 18q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q11 | 2.52e-03 | 85 | 40 | 2 | chr18q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q23 | 4.71e-03 | 117 | 40 | 2 | chr5q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q31 | 6.68e-03 | 140 | 40 | 2 | chr7q31 | |
| GeneFamily | Fibronectin type III domain containing | 6.46e-05 | 160 | 25 | 4 | 555 | |
| GeneFamily | Laminin subunits | 1.20e-04 | 12 | 25 | 2 | 626 | |
| GeneFamily | Wnt family|Endogenous ligands | 3.09e-04 | 19 | 25 | 2 | 360 | |
| GeneFamily | Fibrinogen C domain containing | 5.40e-04 | 25 | 25 | 2 | 554 | |
| Coexpression | NABA_MATRISOME | ADAMTS16 PCSK5 MST1 LAMA3 WNT10A LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 CRIM1 SEMA5B INHBC TNC TNXB VWDE ADAM15 FBN3 MEGF10 WNT16 | 5.09e-21 | 1026 | 40 | 22 | M5889 |
| Coexpression | NABA_MATRISOME | ADAMTS16 PCSK5 MST1 LAMA3 WNT10A LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 CRIM1 SEMA5B INHBC TNC TNXB VWDE ADAM15 MEGF10 WNT16 | 1.03e-19 | 1008 | 40 | 21 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA3 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 CRIM1 TNC TNXB VWDE FBN3 | 1.54e-18 | 196 | 40 | 13 | M3008 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA3 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 CRIM1 TNC TNXB VWDE | 7.39e-17 | 191 | 40 | 12 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | LAMA3 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 CRIM1 TNC TNXB VWDE FBN3 | 1.31e-16 | 275 | 40 | 13 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | LAMA3 LAMB1 SNED1 NTN1 RELN LTBP3 FBN1 FBN2 CRIM1 TNC TNXB VWDE | 4.83e-15 | 270 | 40 | 12 | MM17057 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.32e-06 | 738 | 40 | 9 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.53e-06 | 751 | 40 | 9 | M5885 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 4.20e-06 | 71 | 40 | 4 | M2948 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN | 1.27e-05 | 199 | 40 | 5 | M3622 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 1.91e-05 | 34 | 40 | 3 | M14043 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.13e-05 | 40 | 40 | 3 | M5887 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 3.67e-05 | 1115 | 40 | 9 | M10371 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 4.66e-05 | 261 | 40 | 5 | M1834 | |
| Coexpression | LINDSTEDT_DENDRITIC_CELL_MATURATION_A | 1.11e-04 | 61 | 40 | 3 | M17033 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 1.24e-04 | 11 | 40 | 2 | M566 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.42e-04 | 174 | 40 | 4 | M45676 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 1.44e-04 | 1035 | 40 | 8 | M9898 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.54e-04 | 68 | 40 | 3 | M1406 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 1.55e-04 | 337 | 40 | 5 | M13206 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.57e-04 | 338 | 40 | 5 | MM17064 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.68e-04 | 343 | 40 | 5 | M5883 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 1.96e-04 | 807 | 40 | 7 | M16651 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.06e-04 | 75 | 40 | 3 | MM1143 | |
| Coexpression | KRAS.DF.V1_DN | 2.12e-04 | 193 | 40 | 4 | M2861 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | 2.38e-04 | 199 | 40 | 4 | M3641 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 2.38e-04 | 199 | 40 | 4 | M6198 | |
| Coexpression | GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN | 2.38e-04 | 199 | 40 | 4 | M6205 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN | 2.42e-04 | 200 | 40 | 4 | M3640 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.42e-04 | 200 | 40 | 4 | M5930 | |
| Coexpression | LEE_LIVER_CANCER_HEPATOBLAST | 2.69e-04 | 16 | 40 | 2 | M13123 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 2.70e-04 | 380 | 40 | 5 | M45714 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.87e-04 | 385 | 40 | 5 | M39264 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 2.97e-04 | 211 | 40 | 4 | M12225 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 3.03e-04 | 610 | 40 | 6 | M3854 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.04e-04 | 17 | 40 | 2 | M47995 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_UP | 3.19e-04 | 87 | 40 | 3 | M13671 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP | 3.82e-04 | 19 | 40 | 2 | M12084 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 4.24e-04 | 20 | 40 | 2 | MM17053 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 4.25e-04 | 650 | 40 | 6 | MM1042 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 4.47e-04 | 235 | 40 | 4 | M5311 | |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 4.53e-04 | 98 | 40 | 3 | M40018 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS | 4.95e-04 | 101 | 40 | 3 | M43627 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_UP | 5.09e-04 | 102 | 40 | 3 | MM749 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 5.39e-04 | 104 | 40 | 3 | M45682 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.63e-04 | 23 | 40 | 2 | M48001 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 7.31e-04 | 268 | 40 | 4 | M45796 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 7.34e-04 | 721 | 40 | 6 | M1999 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 7.78e-04 | 27 | 40 | 2 | M47994 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.98e-07 | 288 | 40 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.30e-06 | 437 | 40 | 8 | GSM777046_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ADAMTS16 BOC PCSK5 LAMB1 TM4SF5 FBN1 TENM4 TNC SLC40A1 FKBP5 | 1.53e-06 | 793 | 40 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromBlastocyst-derived-iPSC_top-relative-expression-ranked_500 | 3.10e-06 | 491 | 40 | 8 | PCBC_DE_blastocyst_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_500 | 4.09e-06 | 128 | 40 | 5 | gudmap_developingGonad_e18.5_testes_500_k5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 5.24e-06 | 370 | 40 | 7 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 1.01e-05 | 768 | 40 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.11e-05 | 777 | 40 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | ADAMTS16 BOC WNT10A RELN TENM4 SEMA5B FBN3 MEGF10 DKK2 GPRIN2 | 1.13e-05 | 994 | 40 | 10 | PCBC_EB_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 1.18e-05 | 783 | 40 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 1.42e-05 | 284 | 40 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 2.64e-05 | 188 | 40 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromFibroblast-derived-iPSC_top-relative-expression-ranked_500 | 3.30e-05 | 492 | 40 | 7 | PCBC_DE_fibroblast_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-DefinitiveEndoderm_top-relative-expression-ranked_500 | 3.48e-05 | 496 | 40 | 7 | PCBC_DE_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 3.52e-05 | 497 | 40 | 7 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | 4.48e-05 | 1166 | 40 | 10 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 6.52e-05 | 749 | 40 | 8 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromFibroblast-derived-iPSC_top-relative-expression-ranked_1000 | 6.71e-05 | 977 | 40 | 9 | PCBC_DE_fibroblast_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-DefinitiveEndoderm_top-relative-expression-ranked_1000 | 6.92e-05 | 981 | 40 | 9 | PCBC_DE_1000 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | 6.98e-05 | 982 | 40 | 9 | PCBC_ratio_MESO-5_vs_SC_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 7.20e-05 | 986 | 40 | 9 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#1_top-relative-expression-ranked_500 | 7.33e-05 | 119 | 40 | 4 | gudmap_developingGonad_P2_testes_500_k1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 7.54e-05 | 992 | 40 | 9 | PCBC_EB_blastocyst_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 9.35e-05 | 398 | 40 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 9.55e-05 | 791 | 40 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 9.65e-05 | 247 | 40 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 1.01e-04 | 797 | 40 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | 1.10e-04 | 1298 | 40 | 10 | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 1.27e-04 | 421 | 40 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.30e-04 | 138 | 40 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 1.41e-04 | 429 | 40 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.62e-04 | 146 | 40 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.66e-04 | 147 | 40 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 1.70e-04 | 148 | 40 | 4 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.76e-04 | 281 | 40 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.76e-04 | 281 | 40 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.20e-04 | 466 | 40 | 6 | GSM777050_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.49e-04 | 65 | 40 | 3 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 2.58e-04 | 165 | 40 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 2.64e-04 | 166 | 40 | 4 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.66e-04 | 307 | 40 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500 | 2.73e-04 | 67 | 40 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.78e-04 | 310 | 40 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_200 | 2.85e-04 | 68 | 40 | 3 | gudmap_developingKidney_e13.5_podocyte cells_200_k4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.86e-04 | 489 | 40 | 6 | PCBC_MESO-5_fibroblast_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_top-relative-expression-ranked_500 | 2.92e-04 | 491 | 40 | 6 | PCBC_MESO-5_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 3.02e-04 | 494 | 40 | 6 | PCBC_SC_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 3.05e-04 | 495 | 40 | 6 | PCBC_SC_fibroblast_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_top-relative-expression-ranked_500 | 3.05e-04 | 495 | 40 | 6 | PCBC_SC_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 3.08e-04 | 496 | 40 | 6 | PCBC_EB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.55e-04 | 327 | 40 | 5 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.67e-04 | 181 | 40 | 4 | gudmap_developingGonad_e14.5_ testes_1000_k2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 3.82e-04 | 969 | 40 | 8 | PCBC_MESO-5_fibroblast_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.08e-04 | 337 | 40 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | 4.15e-04 | 981 | 40 | 8 | Arv_EB-LF_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromBlastocyst-derived-iPSC_top-relative-expression-ranked_1000 | 4.15e-04 | 981 | 40 | 8 | PCBC_DE_blastocyst_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_500_k-means-cluster#3 | 4.36e-04 | 342 | 40 | 5 | Arv_SC-LF_500_K3 | |
| CoexpressionAtlas | MESO-15 blastocyst_vs_MESO-15 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 4.53e-04 | 751 | 40 | 7 | PCBC_ratio_MESO-15 blastocyst_vs_MESO-15 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 4.90e-04 | 761 | 40 | 7 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.96e-04 | 196 | 40 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 5.38e-04 | 773 | 40 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.54e-04 | 554 | 40 | 6 | Arv_SC_fibroblast_1000_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.70e-04 | 557 | 40 | 6 | Arv_SC-HD_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 6.39e-04 | 372 | 40 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 6.47e-04 | 1049 | 40 | 8 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.90e-04 | 214 | 40 | 4 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 7.45e-04 | 385 | 40 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | 7.59e-04 | 819 | 40 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 7.72e-04 | 388 | 40 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_500 | 8.32e-04 | 98 | 40 | 3 | gudmap_developingGonad_e14.5_ testes_500_k5 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_100 | 8.57e-04 | 99 | 40 | 3 | PCBC_ratio_DE_vs_SC_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 8.82e-04 | 100 | 40 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 9.37e-04 | 849 | 40 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 9.43e-04 | 850 | 40 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 9.56e-04 | 615 | 40 | 6 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 9.61e-04 | 103 | 40 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500 | 9.67e-04 | 408 | 40 | 5 | gudmap_developingGonad_P2_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500 | 1.01e-03 | 412 | 40 | 5 | gudmap_developingGonad_e18.5_testes_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.06e-03 | 240 | 40 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.07e-03 | 241 | 40 | 4 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.12e-03 | 244 | 40 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | 1.16e-03 | 1148 | 40 | 8 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.19e-03 | 111 | 40 | 3 | ratio_ECTO_vs_SC_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 1.21e-03 | 249 | 40 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 1.21e-03 | 249 | 40 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.29e-03 | 114 | 40 | 3 | gudmap_kidney_P3_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.29e-03 | 114 | 40 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.32e-03 | 115 | 40 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k4_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.34e-03 | 439 | 40 | 5 | GSM777059_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.39e-03 | 117 | 40 | 3 | ratio_EB_vs_SC_1000_K2 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.49e-03 | 450 | 40 | 5 | GSM777063_500 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.51e-03 | 672 | 40 | 6 | JC_iEC_2500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.52e-03 | 265 | 40 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.54e-03 | 453 | 40 | 5 | GSM777067_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.54e-03 | 675 | 40 | 6 | Arv_SC-LF_1000_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#3 | 1.56e-03 | 267 | 40 | 4 | Arv_SC-HD_500_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#1 | 1.56e-03 | 267 | 40 | 4 | Arv_SC_fibroblast_500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.57e-03 | 122 | 40 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.57e-03 | 455 | 40 | 5 | GSM777055_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.77e-03 | 276 | 40 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-12 | 183 | 40 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.23e-12 | 191 | 40 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.95e-10 | 185 | 40 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-10 | 186 | 40 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.82e-10 | 192 | 40 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-10 | 193 | 40 | 7 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-10 | 193 | 40 | 7 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-10 | 193 | 40 | 7 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.41e-10 | 196 | 40 | 7 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.91e-10 | 199 | 40 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.08e-10 | 200 | 40 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.08e-10 | 200 | 40 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-08 | 177 | 40 | 6 | 9b02fd91c110b405eba6cb74ceb90b1286535973 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-08 | 179 | 40 | 6 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-08 | 182 | 40 | 6 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-08 | 182 | 40 | 6 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.52e-08 | 185 | 40 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-08 | 185 | 40 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-08 | 185 | 40 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.68e-08 | 188 | 40 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-08 | 189 | 40 | 6 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-08 | 189 | 40 | 6 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-08 | 189 | 40 | 6 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-08 | 189 | 40 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-08 | 190 | 40 | 6 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.02e-08 | 194 | 40 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.02e-08 | 194 | 40 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-08 | 195 | 40 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.08e-08 | 195 | 40 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-08 | 195 | 40 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-08 | 195 | 40 | 6 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-08 | 195 | 40 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-08 | 195 | 40 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-08 | 196 | 40 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-08 | 196 | 40 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.21e-08 | 197 | 40 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-08 | 197 | 40 | 6 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-08 | 197 | 40 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-08 | 198 | 40 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.35e-08 | 199 | 40 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.35e-08 | 199 | 40 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-08 | 200 | 40 | 6 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-08 | 200 | 40 | 6 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.42e-08 | 200 | 40 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.42e-08 | 200 | 40 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.42e-08 | 200 | 40 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.42e-08 | 200 | 40 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-07 | 170 | 40 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-07 | 170 | 40 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 4.68e-07 | 173 | 40 | 5 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 175 | 40 | 5 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-07 | 181 | 40 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-07 | 181 | 40 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-07 | 181 | 40 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.01e-07 | 182 | 40 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.01e-07 | 182 | 40 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.01e-07 | 182 | 40 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-07 | 183 | 40 | 5 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.18e-07 | 183 | 40 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-07 | 185 | 40 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 185 | 40 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 185 | 40 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 185 | 40 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-07 | 185 | 40 | 5 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.69e-07 | 186 | 40 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.87e-07 | 187 | 40 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-07 | 187 | 40 | 5 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-07 | 187 | 40 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.87e-07 | 187 | 40 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.87e-07 | 187 | 40 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-07 | 188 | 40 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-07 | 188 | 40 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.06e-07 | 188 | 40 | 5 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.06e-07 | 188 | 40 | 5 | 263169029293e005bcffd87db20221fdd2d3917e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.06e-07 | 188 | 40 | 5 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 7.24e-07 | 189 | 40 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 189 | 40 | 5 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.24e-07 | 189 | 40 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.24e-07 | 189 | 40 | 5 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.24e-07 | 189 | 40 | 5 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.44e-07 | 190 | 40 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-07 | 190 | 40 | 5 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.44e-07 | 190 | 40 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-07 | 190 | 40 | 5 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.63e-07 | 191 | 40 | 5 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.63e-07 | 191 | 40 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-07 | 191 | 40 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.83e-07 | 192 | 40 | 5 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-07 | 192 | 40 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.83e-07 | 192 | 40 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-07 | 192 | 40 | 5 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 7.83e-07 | 192 | 40 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-07 | 192 | 40 | 5 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-07 | 192 | 40 | 5 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-07 | 192 | 40 | 5 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.83e-07 | 192 | 40 | 5 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.03e-07 | 193 | 40 | 5 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| Computational | Adhesion molecules. | 9.11e-08 | 141 | 30 | 7 | MODULE_122 | |
| Drug | Rgd Peptide | 2.74e-10 | 239 | 40 | 9 | CID000104802 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 3.39e-07 | 83 | 40 | 5 | CID011968896 | |
| Drug | AC1L9INI | 3.47e-06 | 59 | 40 | 4 | CID000445839 | |
| Drug | hyaluronan | 6.20e-06 | 263 | 40 | 6 | CID000024759 | |
| Drug | Sikvav | 9.91e-06 | 24 | 40 | 3 | CID005487517 | |
| Drug | 3-ethylpyridine | 1.80e-05 | 4 | 40 | 2 | CID000010823 | |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A | 2.31e-05 | 196 | 40 | 5 | 4106_UP | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 40 | 5 | 4120_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.49e-05 | 199 | 40 | 5 | 3058_DN | |
| Drug | Gdrgdsp | 3.98e-05 | 109 | 40 | 4 | CID000115346 | |
| Drug | Ikvav | 4.06e-05 | 38 | 40 | 3 | CID000131343 | |
| Drug | 21-deoxycortisol | 4.39e-05 | 39 | 40 | 3 | CID000092827 | |
| Drug | AC1O5SNJ | 4.49e-05 | 6 | 40 | 2 | CID006439900 | |
| Drug | Vpgvg | 6.28e-05 | 7 | 40 | 2 | CID006452594 | |
| Drug | 17-hydroxyprogesterone | 6.38e-05 | 123 | 40 | 4 | CID000006238 | |
| Drug | chondroitin sulfate | 7.82e-05 | 413 | 40 | 6 | CID000024766 | |
| Drug | funiferine N-oxide | 8.75e-05 | 49 | 40 | 3 | CID000191631 | |
| Drug | rac Geosmin-d3 | 1.08e-04 | 9 | 40 | 2 | CID000001213 | |
| Drug | Methimazole | 1.08e-04 | 438 | 40 | 6 | ctd:D008713 | |
| Drug | desmosine | 1.11e-04 | 53 | 40 | 3 | CID000025435 | |
| Drug | kalinin | 1.24e-04 | 55 | 40 | 3 | CID000032518 | |
| Drug | CC270 | 1.53e-04 | 59 | 40 | 3 | CID006918852 | |
| Drug | AC1L1G72 | 1.64e-04 | 11 | 40 | 2 | CID000003553 | |
| Drug | BM165 | 1.64e-04 | 11 | 40 | 2 | CID003352881 | |
| Drug | 1xqc | 1.64e-04 | 11 | 40 | 2 | CID005287617 | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.13e-09 | 3 | 39 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | Endometrioma | 2.25e-06 | 161 | 39 | 5 | C0269102 | |
| Disease | Endometriosis | 2.25e-06 | 161 | 39 | 5 | C0014175 | |
| Disease | intraocular pressure measurement | 4.16e-06 | 509 | 39 | 7 | EFO_0004695 | |
| Disease | scoliosis (is_implicated_in) | 1.02e-05 | 4 | 39 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Geleophysic dysplasia | 1.70e-05 | 5 | 39 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 1.70e-05 | 5 | 39 | 2 | C0265287 | |
| Disease | Malformation of cortical development | 2.54e-05 | 6 | 39 | 2 | cv:C1955869 | |
| Disease | Lissencephaly | 2.54e-05 | 6 | 39 | 2 | cv:C0266463 | |
| Disease | central corneal thickness | 5.24e-05 | 309 | 39 | 5 | EFO_0005213 | |
| Disease | tenascin measurement | 7.61e-05 | 10 | 39 | 2 | EFO_0008296 | |
| Disease | age at onset, multiple sclerosis | 7.61e-05 | 10 | 39 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | Neurobehavioral Manifestations | 1.11e-04 | 12 | 39 | 2 | C0525041 | |
| Disease | brain cortex volume measurement | 1.32e-04 | 13 | 39 | 2 | EFO_0010287 | |
| Disease | Hypodontia | 1.53e-04 | 14 | 39 | 2 | C0020608 | |
| Disease | cortical surface area measurement | 3.17e-04 | 1345 | 39 | 8 | EFO_0010736 | |
| Disease | Osteoarthritis of hip | 3.19e-04 | 20 | 39 | 2 | C0029410 | |
| Disease | Involutional paraphrenia | 5.01e-04 | 25 | 39 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 5.01e-04 | 25 | 39 | 2 | C1571984 | |
| Disease | Involutional Depression | 5.01e-04 | 25 | 39 | 2 | C0011574 | |
| Disease | osteoarthritis, hip, body mass index | 7.23e-04 | 30 | 39 | 2 | EFO_0004340, EFO_1000786 | |
| Disease | FEV/FEC ratio | 1.02e-03 | 1228 | 39 | 7 | EFO_0004713 | |
| Disease | vital capacity | 1.06e-03 | 1236 | 39 | 7 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ACVGRMGHCCGSAGN | 141 | A8MWP4 | |
| CTQGAEMCRRACGGH | 401 | Q99424 | |
| VIICCCGCQGVGGMR | 426 | A6NF34 | |
| PCAGGQAVCMHGRCA | 511 | Q13444 | |
| CADGQQDCHARGMEC | 2211 | Q75N90 | |
| HRDGMCCPSTRCNNG | 111 | Q9UBU2 | |
| TICGHDMWCRGGQCV | 561 | Q8TE57 | |
| VGGRCKCNGHAARCV | 281 | O95631 | |
| GGLLLHCCACGAVMR | 181 | O95907 | |
| SGQCTCRTGFMGRHC | 771 | Q96KG7 | |
| HLEGRCGGRMFDCRD | 171 | Q13451 | |
| SFHPMAGCEGCNCSR | 1346 | Q16787 | |
| RGIDCQGGSRMCCRQ | 236 | P55103 | |
| GDQEMGECESCHRAC | 1121 | Q92824 | |
| GHNLFCMDCAVRICG | 616 | Q86XN8 | |
| SGQCSCRPHMIGRQC | 526 | P07942 | |
| MCSGRGICDAGRCVC | 1771 | P78509 | |
| CIDMCSGHGRCIQGN | 2481 | P78509 | |
| LCGHGTCQLCGDRMS | 976 | Q86YT6 | |
| SGRACANGIHMNRGC | 926 | Q9BWV1 | |
| RHSCGDGFCSRPNMC | 86 | P35555 | |
| IRCMNGGSCSDDHCL | 121 | P35555 | |
| IAGRHRMDACCCSVG | 971 | P35555 | |
| MDNCRFCRCQGGVAI | 351 | Q9NZV1 | |
| INECAMPGVCRHGDC | 356 | Q9NS15 | |
| VRCMNGGTCADDHCQ | 151 | P35556 | |
| CAGRCGPLMDCRAFH | 56 | P26927 | |
| CGMREVRAGGCCHAL | 236 | O60269 | |
| GKGGQAHRCCCVADR | 181 | P31040 | |
| TMECGSHGVCSRGIC | 696 | Q9UKZ4 | |
| MTRAGDHNRQRGCCG | 1 | Q9NP59 | |
| CHCQAGYMGRRCQAE | 681 | Q8TER0 | |
| GHCMRNNVCVCREGY | 1466 | Q8N2E2 | |
| TCATRMCPADCRGRG | 646 | P22105 | |
| QHGRCVNGMCVCDDG | 476 | P24821 | |
| RCVNGQCVCHEGFMG | 541 | P24821 | |
| MGAACDQRACHPRCA | 751 | Q6N022 | |
| LMSVDCRCHGVSGSC | 216 | Q9UBV4 | |
| SNCGGGMQSRRRACE | 736 | Q9P283 | |
| RCCHECRPGNGMVSR | 41 | P43489 | |
| HNNIFCGVACGRGRM | 251 | O43379 | |
| GCAQGMCCHGRQGTV | 71 | Q71RG6 | |
| CGAGCCGNRCRMLRS | 76 | O14894 | |
| GCGSMCCGRGHNILR | 371 | Q9GZT5 | |
| RRHGVCTDCAGRGMA | 496 | Q86UZ6 | |
| CAMENGGCSHLCLRS | 1006 | O75096 |